These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 37852675)
21. Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study. Xing D; Banet N; Sharma R; Vang R; Ronnett BM; Illei PB Hum Pathol; 2018 Feb; 72():160-166. PubMed ID: 29241740 [TBL] [Abstract][Full Text] [Related]
22. Peritoneal inclusion cysts in adolescent females: a clinicopathological characterization of four cases. Amesse LS; Gibbs P; Hardy J; Jones KR; Pfaff-Amesse T J Pediatr Adolesc Gynecol; 2009 Feb; 22(1):41-8. PubMed ID: 19232301 [TBL] [Abstract][Full Text] [Related]
23. Benign papillary mesothelioma of peritoneum: a histological, histochemical and ultrastructural study of six cases. Goepel JR Histopathology; 1981 Jan; 5(1):21-30. PubMed ID: 7216174 [TBL] [Abstract][Full Text] [Related]
24. [Benign cystic mesothelioma of the peritoneum]. Galil-Ogly GA; Ivanov ED; Bershchanskaia AM Arkh Patol; 1985; 47(12):68-72. PubMed ID: 4096659 [TBL] [Abstract][Full Text] [Related]
25. Pitfalls in Frozen Section: A Case of Incidental Papillary Mesothelioma. Shkolnik E; Marcus J; Heller DS Int J Surg Pathol; 2021 Dec; 29(8):844-846. PubMed ID: 33978505 [TBL] [Abstract][Full Text] [Related]
26. Well-differentiated papillary mesothelioma of the peritoneum: a diagnostic dilemma on fine-needle aspiration cytology. Nasit JG; Dhruva G Am J Clin Pathol; 2014 Aug; 142(2):233-42. PubMed ID: 25015866 [TBL] [Abstract][Full Text] [Related]
27. Peritoneal carcinomatosis: role of (18)F-FDG PET. Turlakow A; Yeung HW; Salmon AS; Macapinlac HA; Larson SM J Nucl Med; 2003 Sep; 44(9):1407-12. PubMed ID: 12960184 [TBL] [Abstract][Full Text] [Related]
28. Mesothelioma In Situ Mimicking Well-differentiated Papillary Mesothelial Tumor. Galateau-Salle F; Hamilton T; MacNeill A; Hofman V; Sequeiros R; Sagan C; Le Stang N; Churg A Am J Surg Pathol; 2023 May; 47(5):611-617. PubMed ID: 36876759 [TBL] [Abstract][Full Text] [Related]
30. Simultaneous occurrence of a rectal carcinoma and a diffuse well differentiated papillary mesothelioma of the peritoneum. Jatzko GR; Jester J Int J Colorectal Dis; 1997; 12(6):326-8. PubMed ID: 9457524 [TBL] [Abstract][Full Text] [Related]
31. Well-differentiated papillary mesothelioma of the peritoneum: a separate entity. Hoekman K; Tognon G; Risse EK; Bloemsma CA; Vermorken JB Eur J Cancer; 1996 Feb; 32A(2):255-8. PubMed ID: 8664037 [TBL] [Abstract][Full Text] [Related]
33. Paratesticular papillary mesothelioma: a case with borderline features. Cabay RJ; Siddiqui NH; Alam S Arch Pathol Lab Med; 2006 Jan; 130(1):90-2. PubMed ID: 16390245 [TBL] [Abstract][Full Text] [Related]
34. Extragastrointestinal stromal tumor of the greater omentum: case report and review of the literature. Nakagawa M; Akasaka Y; Kanai T; Yamashita T; Kuroda M; Takayama H; Miyazawa N Hepatogastroenterology; 2003; 50(51):691-5. PubMed ID: 12828062 [TBL] [Abstract][Full Text] [Related]
35. Procancerogenic activity of senescent cells: A case of the peritoneal mesothelium. Mikuła-Pietrasik J; Stryczyński Ł; Uruski P; Tykarski A; Książek K Ageing Res Rev; 2018 May; 43():1-9. PubMed ID: 29355719 [TBL] [Abstract][Full Text] [Related]
36. Selected topics in peritoneal pathology. Baker PM; Clement PB; Young RH Int J Gynecol Pathol; 2014 Jul; 33(4):393-401. PubMed ID: 24901399 [TBL] [Abstract][Full Text] [Related]
37. Unusual multifocal glomeruloid pattern in a well-differentiated papillary mesothelioma of the peritoneum. Martínez-Consuegra N; Muñoz-Juárez M; Ortiz-Hidalgo C Int J Surg Pathol; 2008 Oct; 16(4):426-7. PubMed ID: 18480398 [No Abstract] [Full Text] [Related]
38. Peritoneal papillary mesothelioma in situ: BAP1 mutation with indolent behavior for 15 years. Vitlarov N; Burtscher E; Pfeiffenberger E; Wahl A; Hodja V; Jasarevic Z; Kashofer K; Offner FA Virchows Arch; 2023 Dec; 483(6):873-878. PubMed ID: 37428268 [TBL] [Abstract][Full Text] [Related]
39. Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion. Estermann M; Huang YL; Septiadi D; Ritz D; Liang CY; Jacob F; Drasler B; Petri-Fink A; Heinzelmann-Schwarz V; Rothen-Rutishauser B PLoS One; 2020; 15(12):e0241500. PubMed ID: 33270665 [TBL] [Abstract][Full Text] [Related]
40. Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions. Hung YP; Chirieac LR Arch Pathol Lab Med; 2024 May; 148(5):e77-e89. PubMed ID: 38190277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]